PEIRETTI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 109.117
NA - Nord America 6.450
AS - Asia 2.746
SA - Sud America 645
AF - Africa 114
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 3
Totale 119.117
Nazione #
IT - Italia 107.138
US - Stati Uniti d'America 6.297
SG - Singapore 1.000
CN - Cina 978
SE - Svezia 538
BR - Brasile 529
UA - Ucraina 344
DE - Germania 288
GB - Regno Unito 238
VN - Vietnam 190
FI - Finlandia 152
IN - India 143
CA - Canada 91
NL - Olanda 90
FR - Francia 67
KR - Corea 55
HK - Hong Kong 45
MX - Messico 40
AU - Australia 37
AR - Argentina 35
RU - Federazione Russa 34
ZA - Sudafrica 34
ES - Italia 33
PH - Filippine 32
BD - Bangladesh 30
CH - Svizzera 30
TR - Turchia 29
AT - Austria 27
TW - Taiwan 25
PK - Pakistan 24
ID - Indonesia 23
PL - Polonia 23
BE - Belgio 22
EG - Egitto 22
IR - Iran 22
IQ - Iraq 21
CL - Cile 20
JP - Giappone 19
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 15
CO - Colombia 15
EC - Ecuador 14
VE - Venezuela 13
GR - Grecia 12
IE - Irlanda 12
MA - Marocco 11
UZ - Uzbekistan 10
MY - Malesia 9
DK - Danimarca 7
IL - Israele 7
JO - Giordania 7
LT - Lituania 7
LY - Libia 7
MU - Mauritius 7
PE - Perù 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
HR - Croazia 6
KZ - Kazakistan 6
NG - Nigeria 6
PT - Portogallo 6
PY - Paraguay 6
RO - Romania 6
DZ - Algeria 5
HU - Ungheria 5
NO - Norvegia 5
NP - Nepal 5
AM - Armenia 4
BN - Brunei Darussalam 4
CZ - Repubblica Ceca 4
KE - Kenya 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
TN - Tunisia 4
AL - Albania 3
BO - Bolivia 3
ET - Etiopia 3
LI - Liechtenstein 3
LK - Sri Lanka 3
UY - Uruguay 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GH - Ghana 2
HN - Honduras 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 119.099
Città #
Cagliari 102.814
Uta 3.869
Ashburn 657
Fairfield 602
Singapore 467
Woodbridge 437
Chandler 399
Dallas 365
Nyköping 356
Houston 337
Boardman 305
Wilmington 268
Seattle 258
Ann Arbor 237
Cambridge 227
Beijing 208
Jacksonville 179
Santa Clara 118
Dearborn 115
Los Angeles 115
New York 95
Hefei 94
Shanghai 94
Boston 73
Helsinki 70
Nanjing 60
Ho Chi Minh City 54
Seoul 53
Buffalo 49
São Paulo 46
The Dalles 42
Milan 39
Rome 37
San Diego 36
Hong Kong 35
Chicago 34
Hanoi 34
Council Bluffs 32
Redondo Beach 32
Munich 31
Dong Ket 26
London 26
Toronto 26
Redwood City 25
Sassari 24
Shenyang 23
Nuremberg 22
Selargius 22
Guangzhou 20
Hebei 19
Nanchang 19
Johannesburg 17
Montreal 17
Tianjin 17
Cedar Knolls 16
Jiaxing 16
Yverdon 16
Amsterdam 15
Atlanta 15
Brooklyn 15
Chennai 15
Phoenix 15
Brussels 14
Changsha 14
Denver 14
Frankfurt am Main 14
Orem 14
Rio de Janeiro 14
Tokyo 14
Warsaw 14
Poplar 13
Mountain View 12
Mumbai 12
Slough 12
Stockholm 12
Zhengzhou 12
Ardabil 11
Augusta 11
Belo Horizonte 11
Manchester 11
Norwalk 11
San Mateo 11
Curitiba 10
Miami 10
Moscow 10
Orange 10
Querétaro 10
Cairo 9
Dhaka 9
Düsseldorf 9
Haiphong 9
Jinan 9
Shenzhen 9
Washington 9
Auburn Hills 8
Baghdad 8
Fortaleza 8
Madrid 8
Mexico City 8
Monmouth Junction 8
Totale 114.211
Nome #
null 3.998
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.168
null 2.985
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.845
Pterygium and glucose-6-phosphate dehydrogenase deficiency 2.840
OCT angiography characteristics in patients with chronic CSCR complicated with polypoidal choroidal vasculopathy 2.104
Comparison of inverted flap and subretinal aspiration technique in full-thickness macular hole surgery: a randomized controlled study 1.987
Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics 1.960
mRNA Level Alterations Of Protein Involved In Cholesterol Ester Metabolism In Pterygium Fibroblast 1.878
Influence of macular choroidal thickness on visual function in highly myopic eyes 1.739
Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts 1.723
Use of a new intra-ocular spectral domain optical coherence tomography in vitreoretinal surgery 1.719
Novel P.Asp304gly mutation in best1 gene associated with atypical best vitelliform macular dystrophy phenotype and high intrafamilial variability 1.718
Photodynamic Therapy with Verteporfin for Corneal Neovascularization 1.699
Iatrogenic retinal breaks in ultrahigh-speed 25-gauge vitrectomy: A prospective study of elective cases 1.686
Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. 1.678
Choroidal neovascularization in caucasian patients with longstanding central serous chorioretinopathy 1.633
null 1.601
Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy 1.540
Unilateral retinitis pigmentosa: A proposal of genetic pathogenic mechanisms 1.519
Terapia Fotodinamica dello Pterigio con Verteporfina 1.516
Bilateral noncalcified astrocytic hamartomas in retinitis pigmentosa: Multimodal imaging evaluation over 8 years of follow-up 1.497
Infrared imaging of choroidal involvement in Leber's idiopathic stellate neuroretinitis 1.492
Proliferative Activity and Cholesterol Ester Metabolism in Primary Culture of Human Pterygium Fibroblasts 1.476
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY SECONDARY TO CHRONIC CENTRAL SEROUS CHORIORETINOPATHY 1.467
Current surgical treatment of age-related macular degeneration 1.447
Strategy for the management of diabetic macular edema: the European Vitreo-Retinal Society macular edema study 1.447
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 1.443
HUMAN AMNIOTIC MEMBRANE TO CLOSE RECURRENT, HIGH MYOPIC MACULAR HOLES IN PATHOLOGIC MYOPIA WITH AXIAL LENGTH OF ≥30 mm 1.434
Analysis of Fundus Autofluorescence in Patients with Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 1.417
Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy 1.404
Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy 1.394
An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study 1.362
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 1.356
null 1.350
Antiproliferative drugs reduce pterygium fibroblast growth rate by modulating cholesterol homeostasis 1.344
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 1.338
Correspondence 1.333
Reliable Therapeutic Modalities to Treat Age-Related Macular Degeneration 1.252
Efficacy and safety of combined vitrectomy with intravitreal dexamethasone implant for advanced stage epiretinal membrane 1.238
Polypoidal choroidal vasculopathy in association with choroidal nevus 1.204
Negative correlation between retinal displacement and ganglion cell layer thickness changes in eyes with epiretinal membrane 1.201
Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-loaded Erythrocyte Ghost Cells. 1.186
Primary vitreoretinal lymphoma masquerading as acute posterior multifocal placoid pigment epitheliopathy 1.176
Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy 1.173
Evaluation of the Choroid in Eyes With Retinitis Pigmentosa and Cystoid Macular Edema 1.157
Polypoidal choroidal vasculopathy associated with tilted disc syndrome 1.132
The nature and frequency of neovascular age-related macular degeneration. 1.060
Photodynamic therapy of pterygium with verteporfin: a preliminary report 1.055
null 1.035
Discrepancy in current central serous chorioretinopathy classification 1.004
Photodynamic therapy in human pterygium. A preliminar report 996
Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium 989
Photodynamic therapy of corneal neovascularization with verteporfin 959
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 956
Unfavorable effect of photodynamic therapy in a multiple detachment of pigment epithelium complicated by choroidal neovascularization 942
Comparison between a fundus camera and scanning laser ophthalmoscope in acquiring fluorescence emission in vitro. 932
Amniotic membrane transplantation in the surgical management of symblepharon following toxic epidermal necrolysis 905
En Face Choroidal Vascularity in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy 901
Pseudo-vitelliform macular detachment and cuticular drusen: Exclusion of 6 candidate genes 890
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. 886
null 851
Simultaneous presentation of idiopathic macular and posterior full-thickness retinal holes successfully treated with inverted internal limiting membrane flap technique. 823
Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. 801
Repopulation of the retinal pigment epithelium after pigment epithelial rip. 788
Photodynamic therapy with Verteporfin (Visudyne) for pterygium 755
Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review. 744
Diagnosis of Age Related Macular Degeneration. 737
Acute central serous chorioretinopathy and fundus autofluorescence 731
Erratum: Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study (BioMed Research International) 724
Macular hole formation following thermal laser photocoagulation in a patient with choroidal neovascular membrane and age-related macular degeneration. 723
Optical Coherence tomography in a case of a double macular hole . 682
Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary Pterygium 671
Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide 659
Choroidal vascularity map in unilateral central serous chorioretinopathy: A comparison with fellow and healthy eyes 631
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 626
null 620
Effect of the First Year of COVID-19 Pandemic on Ophthalmological Practice: A Multi-Centre Italian Study with a Focus on Medico-Legal Aspects 616
Late Effect of Irradiation of Choroidal Circulation. 611
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration 611
Ocular Surface Changes Associated with Face Masks in Healthcare Personnel during COVID-19 Pandemic 575
Unusual clinical manifestation of sclerochoroidal calcifications. 567
Influence of fellow eye on the diagnosis and classification of central serous chorioretinopathy 563
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 556
Oral-ocular trans infection of Epstein Barr virus. A possible new way of transmission by wearing masks in the SARS-CoV-2 era 537
Analysis of Fundus Autofluorescence in Patients With Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 503
Non-neovascular age-related macular degeneration with subretinal fluid 502
Central serous chorioretinopathy imaging biomarkers 497
Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study 495
Multimodal Imaging Based Predictors for the Development of Choroidal Neovascularization in Patients with Central Serous Chorioretinopathy 488
Interocular asymmetry in distribution of leaks in central serous chorioretinopathy 488
Age-related macular degeneration and cognitive impairment show similarities in changes of neutral lipids in peripheral blood mononuclear cells 466
Outer retinal tubulations in central serous chorioretinopathy associated with choroidal neovascularisation 448
INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE for MACULAR HOLE SURGERY WITHOUT EXTRA MANIPULATION of the FLAP 418
Quantitative and Qualitative Assessments of Retinal Structure with Variable A-Scan Rate Spectralis OCT: Insights into IPL Multilaminarity 411
Two-Port “Dry Vitrectomy” as a New Surgical Technique for Rhegmatogenous Retinal Detachment: Focus on Macula-on Results 411
Correlation of sectoral choroidal vascularity with angiographic leakage in central serous chorioretinopathy 403
Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study 402
null 386
Relationship between nerve fiber layer hemorrhages and outcomes in central retinal vein occlusion 359
Totale 114.645
Categoria #
all - tutte 158.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.633 0 0 0 0 0 2.563 2.112 1.154 391 896 939 578
2021/20226.036 572 679 269 195 621 444 361 329 463 540 804 759
2022/202311.689 737 1.409 1.079 992 825 1.102 714 1.222 925 787 1.382 515
2023/202412.400 589 394 355 621 1.233 1.913 2.196 796 508 845 1.473 1.477
2024/202522.136 5.114 5.357 3.587 2.326 1.397 1.392 1.283 304 375 310 277 414
2025/20264.345 611 471 1.242 829 776 416 0 0 0 0 0 0
Totale 119.490